Ansa Biotechnologies is developing a new way to make DNA that will be faster, cleaner, and more accurate than existing methods. Currently, DNA is manufactured via a chemical method that has remained mostly unchanged for 35 years. Our enzyme-based approach promises to dramatically accelerate innovation in biological research and biotechnology, including therapeutics, diagnostics and biomanufacturing.
Location: United States, California, Berkeley
Employees: 1-10
Total raised: $77.2M
Founded date: 2018
Investors 5
| Date | Name | Website |
| - | Fifty Year... | fiftyyears... |
| - | Metaplanet... | metaplanet... |
| 21.08.2022 | Y Combinat... | ycombinato... |
| 06.10.2021 | Mubadala C... | mubadala.c... |
| 21.04.2022 | Altitude L... | altitudels... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 12.04.2022 | Series A | $68M | - |
| 15.09.2020 | Seed | $9.2M | - |
Mentions in press and media 10
| Date | Title | Description |
| 12.04.2022 | Ansa Biotechnologies nabs $68M | Ansa Biotechnologies has raised $68 million in a round led by Northpond Ventures. The company is a developer of DNA synthesis technology designed to advance biological research processes. View round |
| 11.04.2022 | Paradigm, Andreessen Horowitz, and Union Square Ventures sued over alleged ‘rampant fraud’ on Uniswap exchange | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. The most successful crypto funds have taken a hands-on approach with the founders they work with.... |
| 11.04.2022 | Ansa Biotechnologies Closes $68M Series A | EMERYVILLE,CA, Ansa Biotechnologies announced it has closed a Series A financing round of $68M led by Northpond Ventures. >> Click here for more funding data on Ansa Biotechnologies >> To export Ansa Biotechnologies funding ... |
| 11.04.2022 | Ansa Biotechnologies Closes $68M Series A Financing | Ansa Biotechnologies, an Emeryville, CA-based developer of an enzymatic DNA synthesis technology, raised $68m in Series A financing. The round was led by Northpond Ventures, with participation from new investors RA Capital, Blue Water Life ... |
| 17.09.2020 | Ansa Biotechnologies wants to usher in a new era of DNA manufacturing | Daniel Arlow has spent the last eighteen years studying genomics and synthetic biology. The arc of his career has taken the first-time founder of the new startup Ansa Biotechnologies from MIT to the famous Keasling Lab at the University of ... |
| 15.09.2020 | Ansa Biotechnologies Announces $9.2M in Seed and Pre-Seed Financing | Ansa Biotechnologies, a Berkeley, Calif.-based DNA synthesis tech service company, raised $7.9m in seed funding. The round was led by Horizons Ventures, with participation from Mubadala Capital, Humboldt Fund, and additional investors. Comb... |
| 15.09.2020 | Ansa Biotechnologies : Raises $9.2 Million in Combined Seed and Pre-Seed Financing | Ansa Biotechnologies today announced that it has raised $7.9 million in an oversubscribed Seed round of funding led by Horizons Ventures, with participation from Mubadala Capital, Humboldt Fund, and additional investors. Combined with a Pre... |
| 23.05.2020 | Mike Kamdar, The Future Of DNA Writing, And The Business Of Biology | With a new way to write DNA, Mike Kamdar and his team at Molecular Assemblies are poised to disrupt just about any industry you can imagine. |
| 17.01.2020 | Deep tech VCs on what they view as some of the most impactful young startups right now | During this week’s Democratic debate, there was a lot of talk, unsurprisingly, about ensuring the future of this country’s children and grandchildren. Climate change was of particular interest to billionaire Tom Steyer, who said repeatedly ... |
| - | Ansa Biotechnologies Raises $68 Million In Series A Funding | Ansa Biotechnologies recently announced it raised a $68 million round of funding. These are the details. Ansa Biotechnologies recently announced it has closed an oversubscribed Series A financing round of $68 million led by Northpond Ventur... |